联苯苄唑凝胶治疗婴儿花斑癣22例临床效果分析

目的总结分析1%联苯苄唑凝胶治疗婴儿花斑癣的临床疗效及不良反应。方法对22例婴儿花斑癣患者采用外用1%联苯苄唑凝胶治疗2周,总结分析其临床资料。结果外用1%联苯苄唑凝胶2周后,总有效率达到90.91%,真菌清除率达到86.36%。结论联苯苄唑凝胶治疗婴儿花斑癣安全、有效,不良反应少。     

布替萘芬擦剂治疗足癣67例的随机双盲对照多中心临床试验

目的:评价国产1%布替萘芬擦剂治疗足癣的疗效及安全性。方法:以1%联苯苄唑溶液为对照药,对131例足癣进行随机双盲用药,A组67例,B组64例,每日外涂1次,连续4wk,观察其临床和真菌学疗效以及不良反应。结果:A组和B组的治愈率分别为63%和69%,有效率分别为84%和80%,真菌学清除率分别为91%和89%,临床和真菌学疗效2组比较无统计学意义(P>0.05)。A组无不良反应发生,B组2例出现中度局部刺激症状。结论:国产1%布替萘芬擦剂治疗足癣疗效好,安全性高。     

复方联苯苄唑凝胶剂的研制与质量评价

目的:研制联苯苄唑和新霉素等药物凝胶剂的制备工艺与质量评价.方法:用卡波姆-940作基质,三乙醇胺为中和剂,加入联苯苄唑、新霉素等,制成凝胶剂;采用紫外双波长法测定联苯苄唑、新霉素的含量.结果:制备的凝胶剂细腻、光洁、稳定性好,释放药物快, 含量测定简单易行.结论:该凝胶剂配方合理,符合中国药典2000年版的规定.     

Direct Formation of Nanospheres from Amphiphilic β-Cyclodextrin Inclusion Complexes

Purpose. The aim of this work was to develop and characterize a highly loaded nanoparticulate system based on amphiphilic -cyclodextrins (CDs) to facilitate the parenteral administration of poorly soluble antifungal model drugs bifonazole and clotrimazole. Methods. Inclusion complexes were characterized with spectroscopic techniques. Particle size distribution of nanospheres were determined by photon correlation spectroscopy (PCS). Nanospheres were assessed for hemolytic activity. Entrapped and released drug quantities were determined and minimum inhibitory concentration (MIC) values of drugs, amphiphilic -CDs, and drug loaded nanospheres were evaluated. Results. 1:1 inclusion complexes of model drugs with amphiphilic -CDs gave nanospheres <300 nm (polydispersity index < 0.15) by nanoprecipitation technique without using surfactants. By direct preparation from preformed inclusion complexes, loading was increased 2- to 8-fold depending on CD type and loading technique. Conventionally loaded CD nanospheres displayed immediate release whereas preloaded and highly loaded nanospheres liberated model drugs over a period of 1 h reducing the initial burst effect. MIC values of bifonazole and clotrimazole were lowered significantly when associated to amphiphilic -CD nanospheres. Conclusion. Amphiphilic -CDs form nonsurfactant, highly loaded nanospheres with lower hemolytic activity than that of natural CDs directly from inclusion complexes. They enhanced solubility and subsequently therapeutic efficacy of the model drugs.     

1%盐酸布替萘芬乳膏治疗浅部真菌病临床观察

目的：评价1％盐酸布替萘芬乳膏治疗浅部真菌病的临床疗效及安全性，并与1％联苯苄唑凝胶进行比较。方法：对83例浅部真菌病患者进行治疗，其中治疗组43例，外用1％盐酸布替萘芬乳膏，每日1次；对照组40例，外用1％联苯苄唑凝胶，每日1次，体股癣疗程2周，手足癣4周。分别于停药及停药2周时观察记录患者的临床表现及治疗效果。结果：1％盐酸布替萘芬乳膏和1％联苯苄唑凝胶临床疗效相似，停药时临床总有效率分别为90．7％和90．0％，真菌总清除率为93．0％和90．0％；停药2周时临床总有效率分别为97．7％和92．5％，真菌总清除率为100．0％和92．5％。不良反应少。结论：1％盐酸布替萘芬乳膏治疗浅部真菌病疗效显著且安全。     

联苯苄唑洗剂的制备及含量测定

配制联苯苄唑洗剂并采用紫外分光光度法在２５６ｎｍ处测定联苯苄唑的含量。浓度在２～８μｇ／ｍｌ范围内呈良好的线性关系，ｒ＝０．９９９８，平均回收率为９９．８６％，ＲＳＤ为０．５８％。     

白肤唑软膏的研制及测定方法

本文研究了白肤唑软膏的配制和测定，采用双相滴定法是可行的，其回收率为９９．６％，ＲＳＤ为０．３％     

2.1%联苯苄唑乳膏治疗手足癣及体股癣的临床疗效和安全性

目的：探讨2.1%联苯苄唑乳膏对体股癣及手足癣的临床效果判断。方法整群选择该院2012年4月-2014年3月收治的76例体股癣及手足癣患者为研究对象,随机分为对照组38例,采取1%硝酸咪康唑乳膏治疗,观察组38例行2.1%联苯苄唑乳膏治疗,对两组患者治疗后效果进行判断。结果观察组治疗总有效率为92.11%,对照组为73.68%,观察组显著疗效较对照组高(P<0.05);治疗后对两组患者不良反应发生情况观察,对照组为13.16%,观察组为10.53%,差异无统计学意义(P跃0.05)。结论对手足癣及体股癣,采取2.0%联苯苄唑乳膏治疗的安全性高,有满意效果,且具有较高安全性,能被患者所接受,值得临床推广。